tradingkey.logo

BUZZ-Biogen falls on weak 2025 profit forecast

ReutersFeb 12, 2025 12:18 PM

Drugmaker Biogen's shares BIIB.O fall 1.32% to $137.55 premarket

Co forecasts 2025 adj. profit between $15.25/shr and $16.25/shr, below analyst est. of $16.34/shr, according to data compiled by LSEG

Co reports Q4 profit of $3.44/shr, higher than analyst est. of $3.35/shr

BIIB said it expects revenue to decline by a mid-single digit percentage in 2025 compared to 2024

Co posts 2024 rev. of $9.68 bln, down 2% from a year earlier

Stock fell ~42% in the last 12 months

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI